BioSpace News Archive

Business

Biotech Big Bangs Its Way Into New York City Via Beacon Capital’s Incubator

Beacon Capital released the introduction of a unique NYC incubator initiative “Beacon Pharma.

March 20, 2018
·
1 min read
Biotech Beach

Xencor Announces Pricing of Public Offering of Common Stock

Xencor announced the pricing of an underwritten public offering of 7,300,000 shares of its common stock at a price to the public of $31.00 per share.

March 20, 2018
·
2 min read
Business

TSO3 Reports Fourth Quarter and Full Year 2017 Results

TSO3 Inc. reported financial results for the fourth quarter and year ended December 31, 2017.

March 20, 2018
·
9 min read
BioCapital

BioPharmX Cancels Presentation at Oppenheimer’s 28th Annual Healthcare Conference Due to Severe Weather

BioPharmX Corporation announces that it has cancelled its presentation at Oppenheimer’s 28th Annual Healthcare Conference in New York tomorrow, due to the winter storm warnings forecasted for the region.

March 20, 2018
·
1 min read
Drug Development

Phase III IMpower131 Study Showed Genentech’s TECENTRIQ (Atezolizumab) Plus Chemotherapy (Carboplatin and ABRAXANE) Reduced the Risk of Disease Worsening or Death in the Initial Treatment of People with a Type of Advanced Squamous Lung Cancer

Genentech announced that the Phase III IMpower131 study met its co-primary endpoint of progression-free survival (PFS) and demonstrated that the combination of TECENTRIQ®.

March 20, 2018
·
10 min read
Business

Evolva Provides 2017 Financial Results and Business Highlights

Evolva posted its financial results today for the period from 1 January to 31 December 2017, and provided business highlights that illustrate how the Company is executing on its strategic transformation plan which was put in place last August.

March 20, 2018
·
2 min read
Business

Kent Imaging Announces Strategic Partnership to Advance Tissue Assessment

This opportunity adds the Kent device to Allegan Canada’s Medical Aesthetics division with another solution for breast augmentation surgery along with AlloDerm®, Natrelle®, Revolve®, and the Keller Funnel®.

March 20, 2018
·
3 min read
BioMidwest

Americans still wish they saw their dentist more

For a second year, dentists topped the list of health practitioners Americans want to see more often, according to a survey from Delta Dental.

March 20, 2018
·
2 min read
Business

Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento

Bayer and Ginkgo Bioworks announced the official name of its joint venture, Joyn Bio.

March 20, 2018
·
4 min read
Drug Development

Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System

Boston Scientific Corporation announced real-world data from the TRUE-HD study during a late-breaking clinical trial session today at the annual congress of the European Heart Rhythm Association (EHRA) in Barcelona, Spain.

March 20, 2018
·
2 min read